Telescope Innovations CorpCanadian Securities Exchange:TELIView on OTCQB
- LAST PRICE0.4000
- TODAY'S CHANGE (%)-0.0100 (-2.4390%)
- Bid / Lots0.3800/ 2
- Ask / Lots0.4000/ 8
- Open / Previous Close0.3750 / 0.4100
- Day Range
- 52 Week Range
- Volume15,520
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TELI |
|---|---|---|
| 09:32 ET | 4500 | 0.375 |
| 09:37 ET | 500 | 0.38 |
| 09:53 ET | 2500 | 0.38 |
| 11:18 ET | 2500 | 0.38 |
| 01:33 ET | 4500 | 0.38 |
| 03:32 ET | 500 | 0.39 |
| 03:39 ET | 500 | 0.4 |
Oct 29, 2024
Telescope Innovations Announces Scientific Publication on AI-Optimized Production of Battery-Grade Lithium Carbonate, from 8:04AM ET on Tuesday Oct 29, 2024 by Dow Jones
8:04AM ET on Tuesday Oct 29, 2024 by Dow Jones
Oct 15, 2024
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots, from 8:03AM ET on Tuesday Oct 15, 2024 by Dow Jones
8:03AM ET on Tuesday Oct 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Telescope Innovations Corp | 21.5M | -20.9x | --- |
Company Information
Telescope Innovations Corp. is a Canada-based chemical technology company. The Company is developing scalable manufacturing processes and tools for the pharmaceutical and chemical industries. The Company builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Its core technology also enables the discovery of novel molecules of therapeutics. Its suite of analytical and automation technologies, including the Direct Inject Liquid Chromatography (DILC) platform for quantitative, online reaction monitoring. DILC is a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. DILC enables unattended sample capture, quenching, dilution, and analysis using a variety of industry standard CDS platforms, including Agilent OpenLab, Agilent ChemStation, Waters Empower 3, and Shimadzu LabSolutions.
Contact Information
- Headquarters
- Suite 301, 2386 East MallVANCOUVER, BC, Canada V6T 1Z3
- Phone
- 778-262-1189
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ali Pejman
- Chief Executive Officer, Director
- Jason Hein
- Chief Financial Officer
- Robert Chisholm
- Independent Director
- Henry Dubina
- Independent Director
- Robert Mintak
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.5M |
|---|---|
Revenue (TTM) | $3.9M |
Shares Outstanding | 53.7M |
Telescope Innovations Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.02 |
Book Value | $0.05 |
P/E Ratio | -20.9x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -24.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
